XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2017
Stock-Based Compensation [Abstract] |
Stock-Based Compensation |
9. | Stock-Based Compensation
We have adopted equity incentive plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. Except for 265,000 options issued to certain Swedish employees during 2015, all employee, consultant and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants was based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments. Stock Options During the year ended 2015, our shareholders approved the Neonode Inc. 2015 Stock Incentive Plan (the “2015 Plan”) which replaces our 2006 Equity Incentive Plan (the “2006 Plan”). Under the 2015 Plan, 2,100,000 shares of common stock have been reserved for awards, including nonqualified stock option grants and restricted stock grants to officers, employees, non-employee directors and consultants. The terms of the awards granted under the 2015 Plan are set by our compensation committee at its discretion. During the year ended December 31, 2017, no stock options were granted under the 2015 Plan. Accordingly, as of December 31, 2017, we had two equity incentive plans:
| ● | The 2006 Equity Incentive Plan (the “2006 Plan”).
| ● | The 2015 Equity Incentive Plan (the “2015 Plan”).
The following table summarizes information with respect to all options to purchase shares of common stock outstanding under the 2006 Plan and the 2015 Plan at December 31, 2017:
Options Outstanding |  | Options Exercisable |
Range of Exercise Price |  | Number Outstanding at 12/31/17 |  |  | Weighted Average Remaining Contractual Life (years) |  |  | Weighted Average Exercise Price |  |  | Number Exercisable at 12/31/17 |  |  | Weighted Average Exercise Price |
$ 1.44 - $ 3.50 |  |  | 200,000 |  |  |  | 4.30 |  |  | $ | 2.85 |  |  |  | 190,000 |  |  | $ | 2.84 |
$ 3.51 - $ 5.00 |  |  | 1,426,000 |  |  |  | 1.85 |  |  | $ | 4.23 |  |  |  | 1,426,000 |  |  | $ | 4.23 |
$ 5.01 - $ 6.21 |  |  | 130,000 |  |  |  | 2.63 |  |  | $ | 5.98 |  |  |  | 130,000 |  |  | $ | 5.98 |
|  |  | 1,756,000 |  |  |  | 2.18 |  |  | $ | 4.20 |  |  |  | 1,746,000 |  |  | $ | 4.21 |
A summary of the combined activity under all of the stock option plans is set forth below:
|  | Options Outstanding |
|  |  |  |  |  |  |  | Weighted- |  |  |  |
|  |  |  |  |  |  |  | Average |  |  |  |
|  |  |  |  | Weighted- |  |  | Remaining |  |  |  |
|  |  |  |  | Average |  |  | Contractual |  |  | Aggregate |
|  | Number of |  |  | Exercise |  |  | Life |  |  | Intrinsic |
|  | Shares |  |  | Price |  |  | (in years) |  |  | Value |
Options outstanding – January 1, 2015 |  |  | 1,709,400 |  |  | $ | 4.92 |  |  |  |  |  |  |  |  |
Options granted |  |  | 605,000 |  |  |  | 3.57 |  |  |  |  |  |  |  |  |
Options exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Options cancelled or expired |  |  | (130,283 | ) |  |  | 6.03 |  |  |  |  |  |  |  |  |
Options outstanding – December 31, 2015 |  |  | 2,184,117 |  |  | $ | 4.48 |  |  |  |  |  |  |  |  |
Options granted |  |  | 25,000 |  |  |  | 1.44 |  |  |  |  |  |  |  |  |
Options exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Options cancelled or expired |  |  | (363,117 | ) |  |  | 4.73 |  |  |  |  |  |  |  |  |
Options outstanding – December 31, 2016 |  |  | 1,846,000 |  |  | $ | 4.39 |  |  |  |  |  |  |  |  |
Options granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Options exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Options cancelled or expired |  |  | (90,000 | ) |  |  | 8.21 |  |  |  |  |  |  |  |  |
Options outstanding – December 31, 2017 |  |  | 1,756,000 |  |  | $ | 4.20 |  |  |  | 2.18 |  |  | $ | - |
Options exercisable and expected to vest – December 31, 2017 |  |  | 1,756,000 |  |  | $ | 4.20 |  |  |  | 2.18 |  |  | $ | - |
There were no stock options granted during 2017. The assumptions used to value stock options granted to directors, employees and consultants during the years ended December 31, 2016 and 2015 are as follows:
|  | For the year ended |
|  | December 31, 2016 |
Annual dividend yield |  |  | - |
Expected life (years) |  |  | 3.5 |
Risk-free interest rate |  |  | 0.83 | %
Expected volatility |  |  | 65.46 | %
|  | For the year ended |
|  | December 31, 2015 |
Annual dividend yield |  |  | - |
Expected life (years) |  |  | 2.97 |
Risk-free interest rate |  |  | 0.47% - 1.41 | %
Expected volatility |  |  | 60.07% - 72.33 | %
During the years ended December 31, 2017, 2016 and 2015, we recorded $72,000, $255,000 and $1,075,000, respectively, of compensation expense related to the vesting of stock options. The estimated fair value of the stock-based compensation was calculated using the Black-Scholes option pricing model as of the grant date of the stock option. Stock options granted under the 2006 and 2015 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant. During the year ended December 31, 2017, no options were granted. During the year ended December 31, 2016, we granted options to purchase 25,000 shares of our common stock to employees with total grant date estimated fair value of $17,000 computed using the Black-Scholes option pricing model. The weighted-average grant date fair value of the options granted during year ended December 31, 2016 was $0.67 per share. During the year ended December 31, 2015, we granted options to purchase 515,000 shares of our common stock to employees and an option to purchase 90,000 shares of our common stock to four members of our board of directors with total grant date estimated fair value of $0.8 million computed using the Black-Scholes option pricing model. The weighted-average grant date fair value of the options granted during year ended December 31, 2015 was $1.24 per share. Stock-Based Compensation The stock-based compensation expense for the years ended December 31, 2017, 2016 and 2015 reflects the estimated fair value of the vested portion of options granted to directors, employees and non-employees.
|  | Years ended |
|  | December 31, |
|  | 2017 |  |  | 2016 |  |  | 2015 |
(In thousands) |  |  |  |  |  |  |  |  |
Research and development |  | $ | - |  |  | $ | 48 |  |  | $ | 484 |
Sales and marketing |  |  | 50 |  |  |  | 150 |  |  |  | 296 |
General and administrative |  |  | 22 |  |  |  | 57 |  |  |  | 295 |
Stock-based compensation expense |  | $ | 72 |  |  | $ | 255 |  |  | $ | 1,075 |
(In thousands) |  | Remaining unrecognized expense at December 31, 2017 |
Stock-based compensation |  | $ | 11 |
The remaining unrecognized expense related to stock options will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 0.2 years. The estimated fair value of stock-based awards is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration